IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 176 filers reported holding IVERIC BIO INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,155,265 | -23.8% | 80,205 | -52.9% | 0.01% | -82.0% |
| Q1 2023 | $4,140,431 | -57.6% | 170,178 | -62.7% | 0.06% | -65.7% |
| Q4 2022 | $9,756,858 | -16.6% | 455,715 | -30.1% | 0.18% | -20.2% |
| Q3 2022 | $11,696,000 | +98.3% | 651,951 | +6.3% | 0.22% | +36.8% |
| Q2 2022 | $5,899,000 | -34.1% | 613,165 | +15.2% | 0.16% | -31.8% |
| Q1 2022 | $8,956,000 | +177.5% | 532,145 | +175.8% | 0.24% | +139.0% |
| Q4 2021 | $3,227,000 | +723.2% | 192,973 | +210.5% | 0.10% | +669.2% |
| Q2 2021 | $392,000 | +612.7% | 62,150 | +287.0% | 0.01% | +8.3% |
| Q1 2020 | $55,000 | – | 16,060 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |